Abbott: Diabetes Mellitus, Type 2 trials

The registry lists 33 Diabetes Mellitus, Type 2 studies with Abbott as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 1 3Phase 2 10Phase 3 10Phase 4 2No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring SystemsCompletedNCT02283411Not applicableResults posted
• An Evaluation of a Novel Glucose Sensing Technology in Type 2 DiabetesCompletedNCT02082184Not applicableResults posted
• Benefits of Nutritional Ingredients for Type 2 DiabetesWithdrawnNCT06327711Not applicable
• Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated With Basal Insulin in FinlandTerminatedNCT06268821Not applicable
• CGM Use in Adults With Type 2 Diabetes on Basal InsulinActive, not recruitingNCT05944432Not applicable
• Diabetes-specific Formula (DSF) in Individuals With Type 2 DiabetesCompletedNCT05802927Not applicable
• Digitally-Enabled Weight Management Program on T2DMCompletedNCT05483140
• T2 FSL2 Weight LossTerminatedNCT05168306
• Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 DiabetesActive, not recruitingNCT04843527Not applicable
• Diabetes-Specific Formula on Long Term Glycemic ControlCompletedNCT04345497Not applicable
• Diabetes-Specific Formula in Individuals With Type 2 DiabetesCompletedNCT04303754Not applicable
• Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-ProfessionalCompletedNCT02336945
• Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring SystemCompletedNCT02073058
• A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2WithdrawnNCT02009410Phase 4
• A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.CompletedNCT01464320Phase 1
• Post Prandial Glucose Control Proof-of-PrincipleCompletedNCT01326299Phase 2/3
• Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 DiabeticsCompletedNCT01324921Phase 2/3
• Four-Hour Evaluation of a Medical Food in Subjects With Type 2 DiabetesCompletedNCT01188200Phase 3
• A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male VolunteersCompletedNCT01088594Phase 1
• A Safety PK/PD Study of SLV337 in Patients With Type 2 DiabetesCompletedNCT00924534Phase 2
• Interaction Study SLV337/SimvastatinCompletedNCT00924430Phase 1
• Comparison of Nutritional Products for People With Type 2 DiabetesCompletedNCT00797069Phase 3
• Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 DiabetesCompletedNCT00753181Phase 3
• A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 DiabetesCompletedNCT00703482Phase 2
• Comparison of Enteral Products for Tube Fed Patients With Type 2 DiabetesCompletedNCT00544206Phase 2
• An Intervention Program to Control DiabetesCompletedNCT00543621Phase 4
• BMS-646256 in Obese and Overweight Type 2 DiabeticsWithdrawnNCT00541567Phase 2/3
• Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional FormulasCompletedNCT00540488Phase 3
• Comparison of Nutritional Products for People With Type 2 DiabetesCompletedNCT00520065Phase 2
• Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With Type 2 DiabetesCompletedNCT00499148Phase 2/3
• Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaCompletedNCT00490178Phase 3
• Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics StudyTerminatedNCT00362765Phase 2/3
• Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesCompletedNCT00141492Phase 2